Law360, New York (December 12, 2011, 1:51 PM ET) -- Teva Women’s Health Inc. on Thursday settled a patent infringement suit in New Jersey over Watson Pharmaceuticals Inc.’s bid to market a generic version of Teva’s oral contraceptive LoSeasonique.
U.S. District Judge Claire C. Cecchi signed off on a joint stipulation to dismiss the suit with prejudice, saying both parties had agreed to drop claims and counterclaims related to Watson’s plans to produce a generic version of LoSeasonique.
Under the provisions of the settlement agreement, Watson was able to launch its Amethia Lo tablets, the generic...
Teva Settles Suit Over Watson’s Generic LoSeasonique
To view the full article, take a free trial now.
